Skip to content
Get alerts
GovInfoNow
Lower risk Drug recall · FDA · Published May 22, 2020

Teva recalls mixed amphetamine tablets due to potential strength variations

Teva Pharmaceuticals USA recalls 5mg amphetamine tablets with possible mixed strengths. Consumers should check product details and contact the company for guidance.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-1285-2020DrugTeva Pharmaceuticals ›
Take action

Contact the company

Recalling firmTeva Pharmaceuticals USA400 Interpace Pkwy · Parsippany, NJ 07054-1120
✎ GovInfoNow plain-language explainer

Teva Pharmaceuticals is recalling 5mg amphetamine tablets that may contain mixed strengths. This could lead to inconsistent dosing and potential health risks if taken without proper medical supervision. Read more at govinfonow.com/recall/37103-teva-recalls-mixed-amphetamine-tablets-due-to-potential-strength-variations.

Source Summary by GovInfoNow · govinfonow.com/recall/37103-teva-recalls-mixed-amphetamine-tablets-due-to-potential-strength-variations · Updated October 5, 2026 · FDA enforcement record: FDA #D-1285-2020

Cite this page

“Teva recalls mixed amphetamine tablets due to potential strength variations.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37103-teva-recalls-mixed-amphetamine-tablets-due-to-potential-strength-variations. Based on FDA recall #D-1285-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1285-2020%22&limit=1).

The FDA announced on May 22, 2020, that Teva Pharmaceuticals USA is recalling mixed amphetamine salts tablets because some bottles may contain mixed strengths. The agency issued recall number D-1285-2020 for the voluntary Class II action.

How to tell if you have it

  • Brand: Teva Pharmaceuticals
  • Product: Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Amphetamine Salts Product)
  • Strength/Size: 5 mg, 100 count bottles
  • NDC: 0555-0971-02
  • Lot #: 42614718
  • Exp. date: 02/2021
  • Units affected: 33,280 bottles

The hazard

According to the FDA, some bottles may contain mixed strengths of the product.

Context

GovInfoNow's records show Teva Pharmaceuticals USA has 97 other recalls on record since 2013-10-11. Other recent recalls of similar products include Teva Doxylamine Succinate Tablets Recall (2022-01-18), Teva Tretinoin Capsules 10mg Recall (2022-01-10), and Teva Mimvey 1mg/0.5mg Tablets Recalled Due to Mislabeling (2022-01-07). Additional recent recalls include Teva recalls traZODone 50mg tablets with foreign tablets risk (2026-08-24) and Teva Metoprolol Succinate Tablets Recall: Failed Dissolution Specifications (2026-01-29).

How to tell if you have this one

Check for the 5mg amphetamine tablets with NDC : 0555-0971-02. The product was sold with a lot number of 42614718 and expired February 2021.

  • Brand
    Teva Pharmaceuticals
  • Category
    Drug
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide within the United State and Puerto Rico.
  • NDC
    0555-0971-02, 0555-0775-02, 0555-0972-02, 0555-0776-02, 0555-0777-02, 0555-0973-02, 0555-0974-02
Recall numberProduct, codes & lotsQuantity
D-1285-2020Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed Amphetamine Salts Product), 5 mg, 100 count bottles, Rx Only, Teva Pharmaceuticals USA, INC. North Wales, PA 19454, NDC 0555-0971-02; Lot #: 42614718, Exp. date 02/202133,280 bottles
D-1286-2020Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed Amphetamine Salts Product), 15 mg, 100 count bottles, Rx Only, Teva Pharmaceuticals USA, INC. North Wales, PA 19454, NDC 0555-0777-02; Lot #: 42617008, Exp. date 10/202141,348 bottles
D-1287-2020Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed Amphetamine Salts Product), 20 mg, 100 count bottles, Rx Only, Teva Pharmaceuticals USA, INC. North Wales, PA 19454, NDC 0555-0973-02; Lot #: 42617891, exp. date 01/202284,209 bottles
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the NDC code 0555-0971-02 on the bottle label to confirm if you have the recalled product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide within the United State and Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 12 months after the firm started it.

1. Firm started the recall: May 22, 202012. FDA classified it Class II: Jun 4, 202023. Published in FDA’s Enforcement Report: Jun 10, 202034. FDA terminated the recall: May 25, 2021420202021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Teva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva PharmaceuticalsAmerican Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INCApothecary Pharma Recalls Tirzepatide Injections Due to Sterility Risk
Apothecary Pharma LLC

Latest drug recalls

Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026K.C. Pharmaceuticals, Inc. recalls Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO
Leader / TopCare / Crocodile Tears · September 11, 2026Amneal Pharmaceuticals, LLC recalls Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater,
Amneal Pharmaceuticals · September 8, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1285-2020 (May 22, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1285-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA